Mevacor, Pravachol Rx-To-OTC Switches To Be Considered In July

Rx-to-OTC switch applications for the cholesterol-lowering drugs Mevacor and Pravachol will be reviewed during joint meetings of the Nonprescription and Endocrinologic & Metabolic Drugs Advisory Committees July 13 and 14.